Stryker Corp (SYK) Financial Statements

Stryker's financial quality is a mix of strong and moderate signals. The company exhibits good operational health with an 11.4% YoY revenue growth and a robust 19.5% operating margin, suggesting effective cost control and positive operating leverage. The balance sheet is healthy, with a manageable Debt/Equity ratio of 0.71, which aligns with a conservative capital structure. However, when assessed against the framework's quality indicators, some metrics are less compelling. The Return on Equity (ROE) of 14.5% falls below the high-quality threshold of 15-20%. The Free Cash Flow (FCF) Yield of 3.4% is modest, translating to a high P/FCF multiple in the mid-30s, which is not typically favourable for value investors seeking strong cash generation. The profit margin of 12.9% is solid but not exceptional. For growth assessment, the 11.4% revenue growth is consistent but not in the high-double-digit range that might justify a premium multiple. The current P/E of 38.6 is high, especially when the EPS growth implied by the revenue growth and margins is likely lower. Overall, Stryker is a financially sound company with steady growth, but its valuation multiples suggest the market is pricing in near-perfect execution, leaving little margin of safety. Analysis based on data as of 2024-05-15.